Literature DB >> 7772275

B cell activation, tolerance and antigen-presenting function.

P D Hodgkin1, A Basten.   

Abstract

Recent advances in the understanding of the collaboration between T cells and B cells have provided a novel framework within which to analyse the mechanisms of B-cell tolerance and its breakdown. Of particular interest has been the finding that B cell anergy is due to defective antigen receptor mediated functions, while the antigen-processing machinery and CD40-dependent activation pathways are unaffected. Thus, the anergic B cell, which otherwise has a short lifespan, can be rescued by a number of regimes to participate in autoimmune responses.

Entities:  

Mesh:

Year:  1995        PMID: 7772275     DOI: 10.1016/0952-7915(95)80037-9

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  13 in total

1.  Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Authors:  A Greiner; C Knörr; Y Qin; W Sebald; A Schimpl; J Banchereau; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

2.  IL-4 expression delays eosinophil-independent vasculopathy and fibrosis during allograft rejection in the mouse.

Authors:  Edda M Roberts; De Shon Hall; Sharon Ferguson; Susan Minson; Joanna D Davies
Journal:  J Clin Immunol       Date:  2003-03       Impact factor: 8.317

3.  Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain.

Authors:  K L Elkins; C M Bosio; T R Rhinehart-Jones
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

4.  Induction of B-cell immune tolerance by antigen-modified cytotoxic T lymphocytes.

Authors:  Phuong Nguyen; Terrence L Geiger
Journal:  Transplantation       Date:  2010-03-27       Impact factor: 4.939

5.  Lactate dehydrogenase-elevating virus replication persists in liver, spleen, lymph node, and testis tissues and results in accumulation of viral RNA in germinal centers, concomitant with polyclonal activation of B cells.

Authors:  G W Anderson; R R Rowland; G A Palmer; C Even; P G Plagemann
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  TLR7 and CD40 cooperate in IL-6 production via enhanced JNK and AP-1 activation.

Authors:  Tony J Vanden Bush; Gail A Bishop
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

7.  Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients - follow-up and clinical implications.

Authors:  Hela-Felicitas Petereit; Dirk Reske
Journal:  Cerebrospinal Fluid Res       Date:  2005-06-27

Review 8.  Introduction to immunology and autoimmunity.

Authors:  D A Smith; D R Germolec
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

9.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

10.  The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help.

Authors:  D A Fulcher; A B Lyons; S L Korn; M C Cook; C Koleda; C Parish; B Fazekas de St Groth; A Basten
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.